Pfizer's (PFE), OPKO's BLA for Somatrogon Gets CRL From FDA
1 min read
Pfizer’s (PFE), OPKO’s BLA for Somatrogon Gets CRL From FDA
The FDA issues a Complete Response Letter to Pfizer (PFE) and OPKO Health’s biologics certify application for somatrogon to treat growth hormone deficiency in pediatric patients.Read More …